XXII Conferencia Internacional del Sida

La 22 edición de la Conferencia Internacional del SIDA (AIDS 2018) tendrá lugar en Ámsterdam (Países Bajos), entre el 23 y el 27 de julio de 2018.

NAM se complace en anunciar que ha sido designado socio oficial de los medios de comunicación científicos por parte de la Sociedad Internacional del Sida (IAS, en sus siglas en inglés) para cubrir la conferencia.

Informaremos de los principales estudios presentados en la conferencia a través de noticias online (que estarán disponibles en: www.aidsmap.com/aids2018), así como mediante el envío de boletines por correo electrónico que incluirán resúmenes de noticias (se enviarán cuatro durante la semana de la conferencia y otro más a la semana siguiente).

Boletines

Sign up today

Sign up for our free email bulletins:

NAM's news coverage of the 22nd International AIDS Conference has been supported by Gilead Sciences Europe Ltd. and ViiV Healthcare.



Official conference partners

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.